Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ484,5486-0,10
KB5645650,00
PKN61,161,12-1,07
Msft212,84212,921,20
Nokia3,64753,651-0,33
IBM117,71180,12
Daimler AG36,98537-0,52
PFE33,7233,8-0,15
09.07.2020 14:28:00
Indexy online
AD Index online
select
AD Index online
 

  • 09.07.2020 14:21:54
Sartorius AG Preferred Stock (SATG_p.DE, Xetra)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
314,20 0,19 0,60 6 548 030
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 09.07.2020
Popis společnosti
Obecné informace
Název společnostiSartorius AG
TickerSRT
TickerSRT3
Kmenové akcie:Ordinary Shares
Kmenové akcie:Preference Shares
RICSATG_p.DE
RICSATG.DE
ISINDE0007165631
Poslední známé roční výsledky31.12.2019
Poslední známé čtvrtletní výsledky31.03.2020
Počet zaměstnanců k 31.12.2019 9 016
Akcie v oběhu k 31.03.2020 68 388 292
MěnaEUR
Kontaktní informace
UliceOtto-Brenner-Str. 20
MěstoGOETTINGEN
PSČ37079
ZeměGermany
Kontatní osobaPetra Kirchhoff
Funkce kontaktní osobyIndependent Member of the Supervisory Board
Telefon 495 513 080
Fax495513083289
Kontatní telefon495 513 081 686

Business Summary: Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates through two segments: Bioprocess Solutions and Lab Products and Services. The Bioprocess Solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, and filter technology for clarification, among others. The Lab Products and Services segment provides instruments, consumables and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation and membrane filter systems for sterility testing of parenterals.
Financial Summary: BRIEF: For the three months ended 31 March 2020, Sartorius AG revenues increased 17% to EUR509.9M. Net income increased 22% to EUR46.2M. Revenues reflect Bioprocess Solutions segment increase of 21% to EUR394.5M, Lab Products and Services segment increase of 5% to EUR115.6M, EMEA segment increase of 16% to EUR207M, Americas segment increase of 19% to EUR180.7M.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Diagnostic & Testing Equipment
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYScientific & Technical Instr.
MGSECTORTechnology
NAICSAnalytical Laboratory Instrument Manufacturing
NAICSOther Measuring and Controlling Device Manufacturing
NAICSOffices of Other Holding Companies
SICAnalytical Instruments
SICMeasuring/controlling Devices Nec
SICHolding Companies, Nec



  • Poslední aktualizace: 09.07.2020
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Supervisory BoardLothar Kappich6319.07.201719.07.2017
Executive Board Chairman, Chief Executive Officer,Joachim Kreuzburg5511.11.201511.11.2002
Independent Vice Chairman of the Supervisory Board, Employee RepresentativeManfred Zaffke-01.03.201401.03.2014
Chief Financial Officer, Member of the Executive BoardRainer Lehmann4401.03.201701.03.2017
Member of the Executive Board, Head of the Bioprocess Solutions DivisionRene Faber4401.01.201901.01.2019
Member of the Executive Board, Head of the Lab Products & Services DivisionJohn MacKay5701.01.201901.01.2019